EDITORIAL: Vaccine production needs to be scaled up
There is a way Big Pharma can allow developing-country firms to produce the jab while ensuring their intellectual property rights are protected
15 March 2021 - 05:00
Last week, Western nations blocked proposals from SA and India to waive typical intellectual property rules for Covid-19 shots, treatments and other measures until the world reaches herd immunity.
While we sympathise with the stance taken by wealthy nations such as the US, Switzerland and the UK, home to some of the world’s biggest pharmaceutical companies, SA and India deserve praise for bringing the debate about global equitable access to vaccines to the World Trade Organization (WTO)...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.